Fundraising Fox
Eris Biotech
YC W24Lehi, US · Founded 2023 · 2 employees · 2 known investors
Find your way into Eris Biotech
Sign up to see every warm intro you have to Eris Biotech
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Eris Biotech team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Eris Biotech develops small-molecule drugs designed to block immune suppression mechanisms, allowing the immune system to attack solid tumors; the company is initially focusing on mesothelioma treatments.
Founders & leadership· Y Combinator alumni (W24)
Eris Biotech was founded in 2023 by Rachel Garlick and Evita Weagel.
RG
Rachel GarlickCo-FounderRachel Garlick holds a PhD in Immunology from Dartmouth College and has developed cancer immunotherapies. At Eris Biotech, she is building cancer drugs designed to activate immune responses against cancer.
EW
Evita WeagelCo-Founder & CEOEvita Weagel holds a PhD in microbiology and molecular biology with focus on cancer immunology, and is developing immunotherapies targeting cancer.
Investors · 2
Y Combinatorlisted by Y CombinatorSan Francisco · $500K
How we know: the Y Combinator directory · open dataset · 5k.vc investor directory · Not right? Tell us
Orange CollectivereportedDanville
How we know: Y Combinator's founder network · Not right? Tell us
Images
Related companies · 10
Orionis BiosciencesOrionis Biosciences discovers and engineers molecules that connect proteins on or within cells to reprogram disease-driving processes or activate immune responses. It develops therapeutics for cancer, autoimmune diseases, and neurodegenerative disorders through collaborations with industry and academic institutions.
AlixiaAlixia develops therapeutics targeting tumor ecosystems to address cancer drug resistance and age-related diseases. The company integrates biology, biophysics, and computational chemistry to design compounds that disrupt metabolic and inflammatory triggers in multiple cell types within the tumor microenvironment.
IRIS MEDICINEIris Medicine is an early-stage biotech developing RNA therapies based on its small binding RNA (sbRNA) platform, which uses cooperative RNAi binding to selectively silence mutant genes carrying expanded pathologic repeat sequences while preserving healthy alleles. Its lead programs target repeat expansion disorders including Huntington's Disease, C9orf72 ALS, and the Spinocerebellar Ataxias.
Adventris PharmaceuticalsAdventris is a biotechnology company developing cancer immunotherapy treatments.
Velorum TherapeuticsVelorium develops transformational medicines by combining scientific research with patient-focused collaboration. The company operates in the medical research and therapeutic development space.
ExelixisExelixis is an oncology company that discovers and develops cancer treatments, including small molecule therapeutics and biotherapeutics such as antibody-drug conjugates, for patients across multiple tumor types. Its flagship commercial product is CABOMETYX (cabozantinib), and it operates through global development and commercialization partnerships.
Notable LabsNotable Labs operates an automated laboratory that tests combinations of existing drugs against individual patients' blood cancer cells to identify effective treatment options for patients whose cancers have become resistant to standard therapies.
AmyrisAmyris develops a biomanufacturing platform that uses fermentation and microbial engineering to produce natural ingredients and rare compounds at scale for partners across industries such as specialty chemicals, food ingredients, and consumer products. Founded in 2003, the company focuses on sustainable, bio-based sourcing of molecules.
Numerion LabsNumerion combines drug discovery expertise with machine learning and computational chemistry. The company applies AI to drug development.
IQVIAIQVIA is a healthcare data and technology company that supports life sciences organizations in research, clinical development, and commercialization of medicines and medical solutions.
Companies working in the same space as Eris Biotech.
Legal entities · 1
corporate structureEris Biotech, Inc.
In the news
Frequently asked questions
- What does Eris Biotech do?
- Eris Biotech develops small-molecule drugs designed to block immune suppression mechanisms, allowing the immune system to attack solid tumors; the company is initially focusing on mesothelioma treatments.
- Who founded Eris Biotech?
- Eris Biotech was founded by Rachel Garlick, Evita Weagel in 2023.
- Who are Eris Biotech's investors?
- Eris Biotech's investors include Y Combinator, Orange Collective.
- Where is Eris Biotech headquartered?
- Eris Biotech is headquartered in Lehi, US.